In this episode, Badrinath R. Konety, MBBS, walks through key recommendations from the 2026 AUA/SUO Early Detection of Prostate Cancer Guideline amendment.
Badrinath R. Konety
Advertisement
Badrinath R. Konety, MD, is the assistant professor, department of urology, University of Iowa, and chief of the urology service, VA Medical Center, Iowa City.
Articles by Badrinath R. Konety
New bladder cancer data are food for thought, but are not conclusive proof that urologists are over-treating early-stage bladder cancer and running up costs.
The value and timing of chemotherapy in patients undergoing cystectomy for clinically localized bladder cancer has long been controversial. There are myriad reasons supporting both neoadjuvant and adjuvant chemotherapies.
Advertisement
Latest Updated Articles
- Bladder cancer data must be taken in context
August 1st 2009
- Adjuvant chemo for bladder cancer: Are we closer to the truth?
November 1st 2008
Advertisement
Advertisement
Trending on Urology Times
1
Study suggests tamsulosin deprescribing may be appropriate for select men with BPH
2
Trial launches of actinium (225Ac) rhPSMA-10.1 injection in mCRPC
3
FDA greenlights phase 1 study of UGN-501 for NMIBC
4
Urocross shows sustained benefit through 24 months post-removal
5